Skip to main content

Table 1 Phenotype and transfection efficiency of the infused CART cells

From: Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma

Cycle

% CAR

CD3+ (%)

CD3+CD4+ (%)

CD3+CD8+ (%)

CD3+CD56+ (%)

CD8+CD56+ (%)

CD45RO+ (%)

CD62L+ (%)

CCR7+ (%)

CD45RO+CD62L+ CCR7+ (%)

CD45RO+CD62L− CCR7− (%)

EGFR

 1

8.99

99.14

32.77

62.26

18.98

10.64

77.93

51.01

51.3

23.61

22.42

 2

8.98

98.53

16.40

78.29

41.02

36.29

96.99

67.15

71.06

50.82

12.13

 3

8.17

98.66

53.66

45.47

7.25

4.26

94.49

76.87

40.96

20.49

3.54

CD133

6.4

95.2

23.6

71.9

11.23

8.19

94.9

74.1

51.4

41.9

12.3